Past Activities
Treatment of Parkinson's Disease: An Update

Faculty and Program

Workshop Director

Francisco Eduardo C. Cardoso, MD, PhD
Universidade Federal de Minas Gerais (UFMG)
Belo Horizante, Brazil

Workshop Faculty

Joaquim Jose Coutinho Ferreira, MD
Rua Antonio Maria De Sousa
Torres Vedras, Portugal

Oscar S. Gershanik, MD
Favaloro Foundation Institute for Neuroscience
Buenos Aires, Argentina

Anthony E. Lang, MD, FRCPC
Toronto Western Hospital
Toronto, ON, Canada

Andrew J. Lees, MD, FRCP
Reta Lila Weston Institute of Neurological Studies
London, United Kingdom

Program

Morning Session
08.00 - 08.15 Welcome and Introduction - Francisco Cardoso, MD, PhD
08.30 - 09.00 History of Levodopa - Andrew Lees, MD, FRCP
09.00 - 09.30 Levodopa Toxicity - Oscar Gershanik, MD
09.30 - 10.00 Initiating Therapy in PD - Levodopa versus Dopamine Agonists - Anthony Lang, MD, FRCPC
10.00 - 10.30 Break
10.30 - 11.00 Initiating Therapy in PD - Levodopa versus Levodopa plus Entacapone - Andrew Lees, MD, FRCP
11.00 - 11.30 How Evidence Based Medicine Applies to Levodopa - Joaquim Ferreira, MD
11.30 - 12.00 Question and Answer Session
12.00 - 13.00 Lunch
Afternoon Session
13.00 - 13.45 Clinical Management of Motor Complications of Levodopa - Oscar Gershanik, MD
13.45 - 15.30 Surgical Management of Motor Complications of Levodopa - Anthony Lang, MD, FRCPC
15.30 - 16.00 Question and Answer Session
16.00 - 16.15 Break
16.15 - 16.45 Management of Psychosis and Dementia in PD - Joaquim Ferreira, MD
16.45 - 17.15 Case Studies - All Faculty
17.15 - 17.30 Closing Remarks - Francisco Cardoso, MD, PhD
17.30 Adjourn